Shockwave Medical, Inc.

NasdaqGS:SWAV Stock Report

Market Cap: US$12.6b

Shockwave Medical Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Doug Godshall

Chief executive officer

US$9.5m

Total compensation

CEO salary percentage7.6%
CEO tenure7yrs
CEO ownership0.3%
Management average tenure2.3yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Apr 06
Shockwave Medical, Inc.'s (NASDAQ:SWAV) 28% Jump Shows Its Popularity With Investors

Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Mar 24
Is Now An Opportune Moment To Examine Shockwave Medical, Inc. (NASDAQ:SWAV)?

Shockwave Medical: Opening Arteries, Delivering Returns

Feb 28

Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 18
Shockwave Medical, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Feb 06
There's Been No Shortage Of Growth Recently For Shockwave Medical's (NASDAQ:SWAV) Returns On Capital

Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Jan 24
Calculating The Fair Value Of Shockwave Medical, Inc. (NASDAQ:SWAV)

Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

Jan 09
Some Shareholders Feeling Restless Over Shockwave Medical, Inc.'s (NASDAQ:SWAV) P/E Ratio

CEO Compensation Analysis

How has Doug Godshall's remuneration changed compared to Shockwave Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

US$163m

Dec 31 2023US$9mUS$716k

US$147m

Sep 30 2023n/an/a

US$244m

Jun 30 2023n/an/a

US$244m

Mar 31 2023n/an/a

US$241m

Dec 31 2022US$8mUS$644k

US$216m

Sep 30 2022n/an/a

US$88m

Jun 30 2022n/an/a

US$55m

Mar 31 2022n/an/a

US$29m

Dec 31 2021US$7mUS$575k

-US$9m

Sep 30 2021n/an/a

-US$38m

Jun 30 2021n/an/a

-US$53m

Mar 31 2021n/an/a

-US$71m

Dec 31 2020US$5mUS$546k

-US$66m

Sep 30 2020n/an/a

-US$65m

Jun 30 2020n/an/a

-US$65m

Mar 31 2020n/an/a

-US$57m

Dec 31 2019US$2mUS$477k

-US$51m

Sep 30 2019n/an/a

-US$48m

Jun 30 2019n/an/a

-US$45m

Mar 31 2019n/an/a

-US$44m

Dec 31 2018US$511kUS$376k

-US$41m

Compensation vs Market: Doug's total compensation ($USD9.48M) is below average for companies of similar size in the US market ($USD13.65M).

Compensation vs Earnings: Doug's compensation has been consistent with company performance over the past year.

CEO

Doug Godshall (58 yo)

7yrs

Tenure

US$9,478,729

Compensation

Mr. Douglas E. Godshall, also known as Doug, M.B.A., is Director of Saluda Medical, Inc. He serves as Chair of the Board of Galvanize Therapeutics, Inc. since September 2022. He has been the Chief Executiv...

Leadership Team

NamePositionTenureCompensationOwnership
Douglas Godshall
President7yrsUS$9.48m0.29%
$ 36.5m
Isaac Zacharias
President & Chief Commercial Officer1.9yrsUS$3.23m0.15%
$ 18.8m
Daniel Hawkins
Founder and Senior Advisor15.3yrsno datano data
John Adams
Co-Founder and Technical Advisor15.3yrsno datano data
Renee Gaeta
Chief Financial Officerless than a yearno data0.053%
$ 6.7m
Luis Morales
Senior Vice President of Global Operationsless than a yearno datano data
Trinh Phung
Chief Accounting Officer2.3yrsno data0.13%
$ 16.9m
Debbie Kaster
Vice President of Investor Relationsless than a yearno datano data
Hajime Tada
General Counsel & Secretary4.9yrsno datano data
Robert Fletcher
Senior Vice President of Marketing & Market Access7.8yrsno datano data
Dave Cox
Vice President of Salesless than a yearno datano data
Cathy Harnett
Senior Director of Human Resources2.3yrsno datano data

2.3yrs

Average Tenure

52yo

Average Age

Experienced Management: SWAV's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Douglas Godshall
President7yrsUS$9.48m0.29%
$ 36.5m
Antoine Papiernik
Independent Director10.8yrsUS$277.06kno data
Frederic Moll
Independent Director13yrsUS$273.62k0.76%
$ 95.7m
Charles Larkin
Independent Chairman of the Board5.3yrsUS$333.62k0.012%
$ 1.5m
Laura Francis
Independent Director5.3yrsUS$297.37k0.011%
$ 1.4m
Sara Toyloy
Independent Director3.2yrsUS$278.62k0.0052%
$ 651.0k
Maria Sainz
Independent Director3.8yrsUS$289.87k0.0096%
$ 1.2m
Kevin Ballinger
Independent Directorless than a yearUS$508.05kno data
F. Watkins
Independent Director10.9yrsUS$278.62k0.010%
$ 1.3m

5.3yrs

Average Tenure

57yo

Average Age

Experienced Board: SWAV's board of directors are considered experienced (5.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/31 09:47
End of Day Share Price 2024/05/30 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shockwave Medical, Inc. is covered by 12 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Travis SteedBofA Global Research
William PlovanicCanaccord Genuity
Kristen StewartCL King & Associates, Inc.